US health regulator authorizes Pfizer’s Covid pill as Omicron surges
5 years ago(FILES) This handout file photo provided on November 16, 2021, courtesy of Pfizer shows the making of its experimental Covid-19 antiviral pills, Paxlovid, in Freiburg, Germany. - The US Food and Drug Administration (FDA) on December 22, 2021, authorized a Pfizer's Covid pill for high-risk people aged 12 and over, a major milestone in the pandemic that will allow millions to access the treatment. "Today's authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally — a major step forward in the fight against this global pandemic," said FDA scientist Patrizia Cavazzoni. (Photo by Handout / Pfizer / AFP) / RESTRICTED TO EDITORIAL USE - MANDATORY CREDIT "AFP PHOTO / Pfizer " - NO MARKETING - NO ADVERTISING CAMPAIGNS - DISTRIBUTED AS A SERVICE TO CLIENTS
The United States on Wednesday authorized Pfizer's anti-Covid pill for high-risk people aged 12 and up, as a surge of cases driven by the highly infectious Omicron variant threatened holiday plans and Americans struggled to find tests.